Table: Delta-Fly Pharma - 9-MTH parent results

Delta-Fly Pharma

14/02/2025 06:42

Feb 14 (Reuters)- 
             Delta-Fly Pharma, Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to   
                Dec 31, 2024        Dec 31, 2023       Mar 31, 2025  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Operating       loss 1.29         loss 949 mln        loss 1.82    
  Recurring       loss 1.31         loss 971 mln        loss 1.83    
  Net             loss 1.31         loss 972 mln        loss 1.83    
  EPS          loss 153.93 yen     loss 142.09 yen   loss 222.34 yen 
  Ann Div                                NIL               NIL       
  -Q2 div            NIL                 NIL                         
  -Q4 div                                NIL               NIL       
  
  NOTE - Delta-Fly Pharma, Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4598.T